CORE--MOLECULAR IMAGING
核心--分子影像
基本信息
- 批准号:6430486
- 负责人:
- 金额:$ 30.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-19 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Description: (Applicant'sDescription) The Molecular Imaging Core Facility
provides centralized research orientated, computational resources and services
outside the budgetary constraints of most individual laboratories. It is
designed to allow investigators to gather and archive data in a digital
format, acquired by scanning existing hard copy or media, or by directly
acquiring data in a digital format through: Molecular Dynamics Phosphor and
Fluorescent Imager, Alpha Imager - Gel Documentation System, Nikon Eclipse
TE300 Inverted Fluorescent Microscope.
In addition to facilitating analysis and quantitation of data, direct digital
acquisition greatly reduces the time required for data collection and the cost
associated with the use of conventional photographic and audioradiographic
techniques. Additionally, direct digital acquisition improves the quality of
data by exploiting the greater dynamic range available in these digital
formats.
Usage has increased over the last several years due to the addition of a full
time professional employee and the recruitment of additional laboratory based
researchers. The 1999 usage data indicates that Cancer Center Members with
peer-reviewed funded projects utilize 85 percent of the services. From a
total operating cost of $82,796, we are requesting $34,398 from the CCSG
allocation, an amount which represents approximately 42 percent of the total
operating budget. Funds will be used to support a portion of core staff
salaries and service contacts.
描述:(申请人描述)分子成像核心设施
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEEPAK K AGRAWAL其他文献
DEEPAK K AGRAWAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEEPAK K AGRAWAL', 18)}}的其他基金
INDIVIDUALIZING COLON CANCER THERAPY USING HYBRID RNA AND DNA MOLECULAR SIGNATURE
利用混合 RNA 和 DNA 分子特征进行个体化结肠癌治疗
- 批准号:
8283832 - 财政年份:2012
- 资助金额:
$ 30.53万 - 项目类别:














{{item.name}}会员




